Asfiksiye Bağlı Oluşan Kardiyak Arrest Modelinde Levosimendan
Öz
Anahtar Kelimeler
Kaynakça
- Hickey RW, Cohen DM, Strausbaugh S, Dietrich AM. Pediatric patients requiring CPR in the prehospital setting. Ann Emerg Med 1995;25:495-501.
- McCaul CL, McNamara P, Engelberts D, Slorach C, Hornberger LK, Kavanagh BP. The effect of global hypoxia on myocardial function after successful car- diopulmonary resuscitation in a laboratory model. Resuscitation 2006;68:267-75.
- Niemann JT, Stratton SJ, Cruz B, Lewis RJ. Outcome of out-of-hospital postcountershock asystole and pulseless electrical activity versus primary asys- tole and pulseless electrical activity. Crit Care Med 2001;29:2366-70.
- Ng TM. Levosimendan, a new calcium-sensitiz- ing inotrope for heart failure. Pharmacotherapy 2004;24:1366-84.
- Bowman P, Haikala H, Paul RJ. Levosimendan, a cal- cium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desen- sitization. J Pharmacol Exp Ther 1999;288:316-25.
- Kersten JR, Montgomery MW, Pagel PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000;90:5-11.
- Parissis JT, Adamopoulos S, Antoniades C, Kostakis G, Rigas A, Kyrzopoulos S, et al. Effects of levosi- mendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure. Am J Cardiol 2004 May;93:1309-12.
- Reis AG, Nadkarni V, Perondi MB, Grisi S, Berg RA. A prospective investigation into the epidemiology of in-hospital pediatric cardiopulmonary resuscita- tion using the international Utstein reporting style. Pediatrics 2002;109:200-9.
Ayrıntılar
Birincil Dil
Türkçe
Konular
-
Bölüm
-
Yazarlar
Murat Aksun
Bu kişi benim
Gökhan İlhan
Bu kişi benim
Bilgin Emrecan
Bu kişi benim
Bilgin Emrecan
Bu kişi benim
Yayımlanma Tarihi
1 Şubat 2009
Gönderilme Tarihi
6 Ağustos 2014
Kabul Tarihi
-
Yayımlandığı Sayı
Yıl 2009 Cilt: 2009 Sayı: 2